Evidence map›Paper›PMID 38966514›Full record

ArticleJournal of community hospital internal medicine perspectives2024

Outcomes of Upper Gastrointestinal Bleeding in Hospitalized COVID-19 Patients in the United States: A Propensity-score Matched Analysis of a Large National Database.

Moon Ryu, Mohammed Quazi, Niloy Ghosh, Karthik Gangu, Amir H Sohail, Asif Farooq, Babu S Maringanti, Aman Goyal, Anupa Patel, Muhammad S Khan and 1 more

Abstract read
In one paragraph

Article in Journal of community hospital internal medicine perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Moon RyuDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Mohammed QuaziDepartment of Mathematics & Statistics, University of New Mexico, Albuquerque, NM 87131, USA.
Niloy GhoshDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Karthik GanguDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Amir H SohailDepartment of Surgery, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Asif FarooqDepartment of Family and Community Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79409, USA.
Babu S MaringantiDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Aman GoyalDepartment of Internal Medicine, Seth GS Medical College and KEM Hospital, Mumbai, 400012, India.
Anupa PatelDepartment of Family and Community Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79409, USA.
Muhammad S KhanDepartment of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Abu B SheikhDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with cirrhosis that are hospitalized with COVID-19 infection have been found to have worse outcomes. No comparative study has been conducted between gastrointestinal (GI) bleeding in patients with cirrhosis who are diagnosed with COVID-19. We utilized the National Inpatient Sample (NIS) database to perform a retrospective analysis of 24, 050 patients diagnosed with cirrhosis and COVID-19. The identified patients were separated into variceal bleeding, nonvariceal bleeding, and no (or neither) GI bleeding groups. After performing propensity sample matching and multivariate analysis of mortality, we found no significant differences in mortality among the three groups. However, the variceal bleed group had a shorter length of stay (5.67 days lower than the no-bleed group). Esophagogastroduodenoscopy (EGD) with intervention was associated with reduced mortality in the variceal and nonvariceal bleeding groups. Acute kidney injury was a strong predictor of mortality in both bleeding groups. A native American race was found to be associated with higher mortality in the nonvariceal bleeding group. Our study suggests that there are various pathophysiological processes among the three groups, with no significant mortality differences with cirrhosis complications of GI bleeding.

Indexed as

Acute kidney injuryCoronavirus diseaseEsophageal varicesGastrointestinal bleedingGastrointestinal complicationsLiver cirrhosis

Identifiers

PMID38966514
PMCPMC11221441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.